Effect of inhaled fluticasone propionate on laryngotracheal stenosis after balloon dilation: a randomized controlled trial
Autor: | Mohammed Almohizea, Ahmed Alammar, Abdulmajeed Zakzouk, Abdullah Aljasser, Syed Shahid Habib, Manal Bukhari, Abdulaziz Alrabiah, Ahmed A. Al-Sayed |
---|---|
Rok vydání: | 2021 |
Předmět: |
Adult
Spirometry medicine.medical_specialty Subglottic stenosis Constriction Pathologic Fluticasone propionate Pulmonary function testing law.invention Laryngology 03 medical and health sciences Fluticasone propionate inhaler Wound healing modifying agent 0302 clinical medicine Randomized controlled trial Inhaled corticosteroid law medicine Humans Prospective Studies Laryngotracheal stenosis 030223 otorhinolaryngology medicine.diagnostic_test business.industry Pulmonary function test Laryngostenosis General Medicine medicine.disease Dilatation Adjuvant medical therapy Surgery Tracheal Stenosis Treatment Outcome Otorhinolaryngology 030220 oncology & carcinogenesis Balloon dilation Fluticasone business medicine.drug |
Zdroj: | European Archives of Oto-Rhino-Laryngology |
ISSN: | 1434-4726 0937-4477 |
Popis: | Purpose Laryngotracheal stenosis describes various airflow compromising conditions leading to laryngeal and tracheal narrowing, including subglottic and tracheal stenosis. Direct laryngobronchoscopy is the diagnostic gold standard for laryngotracheal stenosis. This study aimed to explore the effect of inhaled fluticasone propionate as adjuvant medical therapy in patients with laryngotracheal stenosis after balloon dilation. Methods This prospective randomized controlled trial was conducted from April 2019 to April 2020. Fourteen adults (≥ 18 years) with laryngotracheal stenosis consented to participate. All patients underwent endoscopic balloon dilation. Seven patients were treated with inhaled fluticasone propionate, and seven acted as controls. Detailed documentation of operative findings and pre- and post-balloon dilation spirometry measurements were recorded. Basic demographic data and operative details, including information about the percentage of laryngotracheal stenosis, distance of laryngotracheal stenosis from the vocal cords, the stenotic segment vertical length, and the largest endotracheal tube used before and after dilation were noted. Results Spirometry measurements were obtained on 34 occasions (17 before and 17 after balloon dilation). The two groups were similar in spirometry values after treatment. Both groups had significantly improved on most spirometry values after balloon dilation. Conclusion We found that using inhaled steroids after balloon dilatation in patients with laryngotracheal stenosis had no benefit over non-user patients in spirometry parameters during the short postoperative follow-up. To confirm this outcome, we recommend a large-scale double-blind study with a longer follow-up period. Supplementary Information The online version contains supplementary material available at 10.1007/s00405-021-06622-x. |
Databáze: | OpenAIRE |
Externí odkaz: |